North America remains a dominant regional hub for digital PCR technology adoption due to the presence of leading biotechnology companies, well-established diagnostic laboratories, and a robust research and development landscape. The region is witnessing increased implementation of advanced molecular diagnostic tools for disease detection, drug development, and clinical research applications....